Brominated 2,2′-Bipyridines and 2,2′-Bipyrimidines
J . Org. Chem., Vol. 67, No. 2, 2002 447
4.8 Hz, J ) 1.0 Hz, 1 H, H5′), 7.79 (td, J ) 7.4 Hz, J ) 1.8 Hz,
1 H, H4′), 7.90 (dd, J ) 2.4 Hz, J ) 8.5 Hz, 1 H, H4), 8.29 (d,
J ) 8.5 Hz, 1 H, H3′), 8.34 (d, J ) 8.5 Hz, 1 H, H3), 8.64 (dt,
J ) 4.8 Hz, J ) 1.0 Hz, 1 H, H6′), 8.69 (d, J ) 2.4 Hz, 1 H,
H6). Romero and Ziessel2 reported a 13C NMR spectrum with
only 9 signals; our data reveal the expected 10 peaks: 13C {1H}
NMR (CDCl3, 124 MHz) δ 120.92 (Cbipy), 121.09 (Cbipy-Br),
122.29 (Cbipy), 123.96 (Cbipy), 136.97 (Cbipy), 139.45 (Cbipy), 149.21
(Cbipy), 150.15 (Cbipy), 154.58 (Cbipy), 155.13 (Cbipy).
mL). The combined organic layers were dried over Na2SO4,
and the solvents were evaporated. The crude product mixture
was separated by PTLC (silica, 5:1 hexanes/ethyl acetate).
Some unreacted 7 was also recovered (15 mg, 10%), but the
main product isolated was 5,5′-dibutyl-3-iodo-2,2′-bipyridine
as a yellow-orange oil (10, 137 mg, 69%): 1H NMR (CDCl3,
300 MHz) δ 0.80 (t, 3 H, J ) 7.3 Hz), 0.87 (t, 3 H, J ) 7.3 Hz),
1.25 (m, 2 H), 1.35 (m, 2 H), 1.47 (m, 2 H), 1.61 (m, 2 H), 2.64
(t, 2 H, J ) 7.7 Hz), 2.82 (t, 2 H, J ) 7.7 Hz), 7.57 (d, 1 H,
J ) 2.1 Hz), 7.62 (d, 1 H, J ) 8.1 Hz), 7.92 (d, 1 H, J ) 2.1
Hz), 8.45 (s, 1 H), 8.67 (d, 1 H, J ) 2.1 Hz); 13C {1H} NMR
(CDCl3, 124 MHz) δ 13.69 (CH3-), 13.79 (CH3-), 22.12
(-CH2-), 22.39 (-CH2-), 31.94 (-CH2-), 32.47 (-CH2-),
32.79 (-CH2-pyr), 33.11 (-CH2-pyr), 92.67 (C-I), 123.56
(Cpyr-H), 136.39 (Cpyr-H), 137.24 (Cpyr-H), 139.31 (Cpyr-H),
146.05 (Cpyr-H), 148.63 (Cpyr-H), 152.33 (Cpyr-H), 155.09
(Cpyr-H), 155.55 (Cpyr-H); MS (EI+) m/z (rel intensity) 394
([M]+, 45), 365 ([M - C2H5]+, 100), 351 ([M - C3H7]+, 15), 322
(5), 308 (3), 267 ([M - I]+, 4), 238 (6), 195 (5), 128 ([I]+, 3), 77
(2); IR (KBr) 634, 750, 789, 848, 866, 888, 901, 931, 1026, 1039,
1079, 1109, 1130, 1155, 1193, 1259, 1305, 1378, 1431, 1463,
1485, 1531, 1568, 1595, 2857, 2928, 2956, 3031; HRMS calcd
394.0906, found 394.0921.
5,5-Dibr om o-2,2′-bip yr id in e (3).2 2,5-Dibromopyridine (4,
1.00 g, 4.33 mmol) was charged into a flask, evacuated, and
put under argon. Anhydrous m-xylene (35 mL) was added from
a syringe, followed by hexa-n-butyldistannane (1.18 mL, 50
mol %). Argon was bubbled through the stirred solution for 1
h before Pd(PPh3)4 (0.117 g, 0.101 mmol) was added from a
tip tube. The reaction mixture was heated to 130 °C for 3 days
until all starting material was consumed and poured into
aqueous EDTA (1 M, 25 mL). After the mixture was stirred
for 15 min, the phases were separated. The aqueous phase was
extracted with chloroform (3 × 50 mL), and the combined
organic phases were dried over Na2SO4. After evaporation of
the solvents, the crude product was flash chromatographed
(alumina, 5:1 hexanes/ethyl acetate), yielding 5,5-dibromo-2,2′-
1
bipyridine (3) as a white solid (95% by H NMR, 0.52 g, 78%).
5-n -Bu tyl-2-iod op yr id in e (13). Freshly distilled 3-n-bu-
tylpyridine (7, 2.5 g, 0.0185 mol) was rinsed into a flask with
dry ether (25 mL) and cooled to 0 °C under stirring. BF3
etherate (2.5 mL, 0.019 mol) was added dropwise, and the
mixture was stirred at 0 °C for 2 h. In the meantime, ZnCl2
(0.5 M in THF, 67.2 mL) was placed in a separate flask and
cooled to -78 °C under stirring. Under argon, t-BuLi (1.7 M
in pentane, 58 mL, 0.0983 mol) was added dropwise but
rapidly, and the clear, yellow reaction mixture was slowly
warmed to room temperature and stirred for 15 min before
recooling to -78 °C. In a third flask, 2,2,6,6-tetramethylpi-
peridine (6.9 mL, 0.0407 mol) was put under argon and cooled
to 0 °C. Under stirring, n-BuLi (1.6 M in hexanes, 26.0 mL)
was added dropwise, and the reaction mixture was stirred for
30 min before warming up to room temperature. After 30 min,
the flask was cooled to -78 °C under continued stirring and
the di-tert-butylzinc solution was added slowly through a
cannula over 20 min. The mixture was stirred vigorously until
all solids were dissolved, yielding a clear, yellow solution. The
solution was stirred for 30 min at -78 °C before warming to
room temperature for 15 min. After the solution was recooled
to -78 °C, the ether solution of the pyridine‚BF3 complex was
added through a cannula in small portions. The reaction
mixture turned orange immediately and then brown. The
reaction mixture was stirred for 2 h at -78 °C at which time
the color had turned to dark red. In a fourth flask, freshly
sublimed iodine (18.8 g, 0.074 mol) was placed under argon,
dissolved in dry diethyl ether (100 mL), and cooled to 0 °C.
The solution was added to the pyridinium zincate through a
cannula over 5 min. Then, the reaction mixture was slowly
warmed to room temperature overnight and poured into a
saturated aqueous solution of sodium sulfite (100 mL). Fol-
lowing vigorous mixing, the two layers were separated and
the aqueous layer was extracted with diethyl ether (3 × 50
mL). The combined organic layers were washed once more with
sodium sulfite solution (2 × 50 mL), and after drying over Na2-
SO4, the organic solvents were evaporated under reduced
pressure. The crude product was chromatographed (alumina,
10:1 hexanes/ethyl acetate), and 13 was recovered as a
The product 3 was further purified by PTLC (alumina, 8:1
hexanes/ethyl acetate) and obtained as colorless plates after
recrystallization from chloroform: mp 201 °C (lit.2 205 °C);
1H NMR (CDCl3, 300 MHz) δ 7.91 (dd, J ) 2.4 Hz, J ) 8.5 Hz,
2 H, H4), 8.26 (d, J ) 8.5 Hz, 2 H, H3), 8.68 (d, J ) 2.4 Hz, 2
H, H6).
2-Tr im eth ylsta n n ylp yr id in e (5).9 Freshly distilled 2-bro-
mopyridine (8.5 g, 5.2 mL, 0.053 mol) was charged into a flask,
evacuated, and put under argon. Dry diethyl ether (100 mL)
was added from a syringe under stirring, and the solution was
cooled to -78 °C in a dry ice/acetone bath. n-BuLi (2.0 M in
cyclohexane, 29 mL, 0.058 mol) was added dropwise from a
syringe, and the reaction mixture was stirred for 2 h under
continued cooling. Then, trimethylstannyl chloride (1.0 M in
THF, 58 mL, 0.058 mol) was added dropwise from a syringe.
After 3 h, the reaction mixture was allowed to warm slowly to
room temperature overnight. The solvents were evaporated
directly from the reaction flask under reduced pressure. Dry
hexanes (100 mL) were added from a syringe, and the slurry
was stirred for 10 min. Following filtration through a frit under
argon, the hexanes were evaporated under reduced pressure
and the crude product (5, 11.5 g, 88%, 96% purity by 1H NMR)
was used in the next step without further purification: 1H
NMR (CDCl3, 500 MHz) δ 0.33 (s, 9 H, J SnH ) 27 Hz, SnCH3),
7.12 (ddd, 1 H, J ) 6.1 Hz, J ) 4.8 Hz, J ) 1.5 Hz, H5), 7.42
(dt, 1 H, J ) 6.9 Hz, J ) 0.9 Hz, H3), 7.50 (td, 1 H, J ) 6.9
Hz, J ) 1.5 Hz, H4), 8.72 (dt, 1 H, J ) 4.8 Hz, J ) 0.9 Hz,
H6).9
5,5′-Dibu tyl-3-iod o-2,2′-bip yr id in e (10). Freshly distilled,
dry 3-n-butylpyridine (7,135 mg, 0.001 mol) was transferred
by a syringe to a two-neck flask filled with argon. Under
stirring, dry diethyl ether (10 mL) was added from a syringe
and the clear, colorless solution was cooled to 0 °C. Then, BF3
etherate (0.125 mL, 0.001 mol) was added dropwise and the
reaction mixture was stirred at 0 °C for 30 min. In a second
flask, freshly distilled 2,2,6,6-tetramethylpiperidine (0.186 mL,
0.0011 mol) was stirred under argon and cooled to 0 °C in an
ice bath. n-BuLi (2 M in cyclohexane, 0.6 mL, 0.0012 mol) was
added dropwise from a syringe, and the reaction mixture was
stirred for 20 min before the solution was warmed to room
temperature. Dry THF (15 mL) was added from a syringe
along with TMEDA (0.098 mL, 0.0012 mol). The yellow, clear
solution was stirred for 15 min and transferred to a syringe.
Then, the solution containing the pyridine‚BF3 complex was
cooled to -78 °C and the base was added dropwise. The orange-
red solution was stirred for 20 min before freshly sublimed
iodine (550 mg, 0.002 mol) dissolved in diethyl ether (10 mL)
was added via cannula. After stirring for an additional 2 h
below -30 °C, the reaction mixture was poured into aqueous
Na2SO3 and shaken vigorously. The phases were separated,
and the aqueous layer was extracted with chloroform (3 × 15
1
yellowish oil: 3.8 g (79%, 98% purity by 1H NMR); H NMR
(CDCl3, 500 MHz) δ 0.87 (t, J ) 7.3 Hz, 3 H, CH3), 1.30 (m, 2
H, CH2-CH3), 1.52 (m, 2 H, CH2), 2.49 (t, J ) 7.7 Hz, 2 H,
Cpyr-CH2), 7.10 (dd, J ) 8.1 Hz, J ) 2.5 Hz, 1 H, Cpyr-H),
7.56 (d, J ) 8.1 Hz, 1 H, Cpyr-H), 8.25 (d, J ) 2.5 Hz, 1 H,
Cpyr-H); 13C {1H} NMR (CDCl3, 124 MHz) δ 13.73 (CH3-CH2),
22.05 (CH2), 31.94 (CH2), 32.94 (CH2-Cpyr), 114.40 (Cpyr-I),
134.27 (Cpyr), 137.59 (Cpyr), 137.80 (Cpyr), 150.88 (Cpyr); IR
(NaCl) 513, 622, 641, 729, 788, 818, 833, 934, 1019, 1070, 1128,
1210, 1377, 1451, 1552, 1575, 2858, 2929, 2956, 3034 cm-1
MS (EI+) m/z (rel intensity) 261 ([M]+, 35), 218 ([M - C3H7]+,
;